EnteroMedics Provides Corporate Update

EnteroMedics, which develops medical devices for obesity, metabolic diseases and gastrointestinal disorders, today provides a corporate update.
According to the press release:

“EnteroMedics continued to drive opportunities to expand the Company’s commercial reach, including the announcement of a third adjunctive rescue surgery for a failed gastric sleeve using the Company’s vBloc® Neurometabolic Therapy … patients from those surgeries are reporting weight-loss results in-line with expectations based on the nature of the surgeries.”

The press release goes on to note:

“The Company expanded its current partnerships by announcing that vBloc Therapy is now available to all U.S. veterans at Department of Veterans Affairs (VA) Medical Facilities.”

Read the full press release here.